Table 2. Localization of cancer and ongoing cancer treatment in patients with proximal or distal deep vein thrombosis.
| Cancer-associated deep vein thrombosis ( n = 235) | ||
|---|---|---|
| Proximal ( n = 177) | Distal ( n = 58) | |
| Localization | ||
| Colon, n (%) | 35 (19.8) | 5 (8.6) |
| Lung, n (%) | 12 (6.8) | 7 (12.1) |
| Breast, n (%) | 12 (6.8) | 4 (6.9) |
| Pancreas, n (%) | 5 (2.8) | 5 (8.6) |
| Leukemia, n (%) | 33 (18.6) | 6 (10.3) |
| Myeloproliferative, n (%) | 6 (3.4) | 1 (1.7) |
| Gynecological, n (%) | 20 (11.3) | 4 (6.9) |
| Kidney, n (%) | 14 (7.9) | 3 (5.2) |
| Gastric, n (%) | 9 (5.1) | 8 (13.8) |
| Central nervous system, n (%) | 7 (4.0) | 2 (3.4) |
| Liver, n (%) | 7 (4.0) | 4 (6.9) |
| Metastatic cancer, n (%) | 58 (32.8) | 15 (25.9) |
| Cancer treatment | ||
| Chemotherapy, n (%) | 72 (40.7) | 21 (36.2) |
| Radiotherapy, n (%) | 12 (6.8) | 5 (8.6) |
| Hormonal treatment, n (%) | 12 (6.8) | 5 (8.6) |